Akanda Corp. (AKAN) vs cbdMD, Inc. (YCBD)

Akanda Corp. and cbdMD, Inc. are both Drug Manufacturers Specialty & Generic companies. cbdMD, Inc. is the larger, with a market value of $4.8M against $2.4M — 2.0× the size. Across the 10 metrics below, Akanda Corp. leads on 8 and cbdMD, Inc. on 2.

Valuation

Metric AKAN YCBD Drug Manufacturers Specialty & Generic median
P/E — 55.29 20.14
P/S n/m 0.24 2.25
P/B n/m 0.61 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m n/m 12.29
EV/Sales n/m 0.26 2.56
Earnings yield — 1.81% (2.99%)
Free cash flow yield 0.00% (49.69%) 0.00%

Profitability

Metric AKAN YCBD Drug Manufacturers Specialty & Generic median
Gross margin — 57.68% 53.94%
Operating margin — (13.87%) 0.00%
Net margin — (14.71%) 0.00%
Free cash flow margin 0.00% (11.51%) 0.00%
Return on equity 0.00% (43.01%) (0.40%)
Return on assets 0.00% (26.73%) (3.32%)
Return on invested capital 0.00% (29.78%) 0.00%

Growth

Metric AKAN YCBD Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 10.01% 10.01%
EPS growth (last fiscal year) (139.63%) 92.39% —
Revenue growth, 5-year CAGR 44.20% (14.45%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AKAN YCBD Drug Manufacturers Specialty & Generic median
Debt to equity (1.08) 0.00 0.05
Current ratio 0.58 2.50 2.31
Net debt to EBITDA (2.75) 6.17 0.85

Dividend

Metric AKAN YCBD Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric AKAN YCBD Drug Manufacturers Specialty & Generic median
Market cap 2.44m 4.76m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack